N'-(2-chloro-6-fluorobenzoyl)-1-prop-2-enoylpiperidine-3-carbohydrazide
C16H17ClFN3O3 — CID 166413000
Data last refreshed: (MolForge compound catalog, from PubChem)
About N'-(2-chloro-6-fluorobenzoyl)-1-prop-2-enoylpiperidine-3-carbohydrazide
N'-(2-chloro-6-fluorobenzoyl)-1-prop-2-enoylpiperidine-3-carbohydrazide (PubChem CID 166413000) has the molecular formula C16H17ClFN3O3 and a molecular weight of 353.78 g/mol. Its IUPAC name is N'-(2-chloro-6-fluorobenzoyl)-1-prop-2-enoylpiperidine-3-carbohydrazide.
Molecular Properties
| Compound Name | N'-(2-chloro-6-fluorobenzoyl)-1-prop-2-enoylpiperidine-3-carbohydrazide |
|---|---|
| PubChem CID | 166413000 |
| Molecular Formula | C16H17ClFN3O3 |
| Molecular Weight | 353.78 g/mol |
| Exact Mass | 353.09 |
| IUPAC Name | N'-(2-chloro-6-fluorobenzoyl)-1-prop-2-enoylpiperidine-3-carbohydrazide |
| SMILES | C=CC(=O)N1CCCC(C(=O)NNC(=O)c2c(F)cccc2Cl)C1 |
| InChI | InChI=1S/C16H17ClFN3O3/c1-2-13(22)21-8-4-5-10(9-21)15(23)19-20-16(24)14-11(17)6-3-7-12(14)18/h2-3,6-7,10H,1,4-5,8-9H2,(H,19,23)(H,20,24) |
| InChIKey | UPGADZZIBSGOIG-UHFFFAOYSA-N |
| XLogP | 1.66 |
| TPSA | 78.51 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 353.78 |
| LogP ≤ 5 | 1.66 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 166413000 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.